AU2283895A - Defective herpes and defective adeno-associated virus vectors with p53 for the treatment of cancer - Google Patents

Defective herpes and defective adeno-associated virus vectors with p53 for the treatment of cancer

Info

Publication number
AU2283895A
AU2283895A AU22838/95A AU2283895A AU2283895A AU 2283895 A AU2283895 A AU 2283895A AU 22838/95 A AU22838/95 A AU 22838/95A AU 2283895 A AU2283895 A AU 2283895A AU 2283895 A AU2283895 A AU 2283895A
Authority
AU
Australia
Prior art keywords
defective
cancer
treatment
associated virus
virus vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22838/95A
Inventor
Michael G Kaplitt
Patricio Meneses
Myrna R Rosenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2283895A publication Critical patent/AU2283895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU22838/95A 1994-04-11 1995-04-11 Defective herpes and defective adeno-associated virus vectors with p53 for the treatment of cancer Abandoned AU2283895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22607294A 1994-04-11 1994-04-11
US226072 1994-04-11
PCT/US1995/004418 WO1995027494A1 (en) 1994-04-11 1995-04-11 DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER

Publications (1)

Publication Number Publication Date
AU2283895A true AU2283895A (en) 1995-10-30

Family

ID=22847433

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22838/95A Abandoned AU2283895A (en) 1994-04-11 1995-04-11 Defective herpes and defective adeno-associated virus vectors with p53 for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU2283895A (en)
WO (1) WO1995027494A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851826A (en) * 1995-07-26 1998-12-22 Children's Medical Center Corporation Helper virus-free herpesvirus vector packaging system
DE19608751B4 (en) 1996-03-06 2006-05-18 Medigene Ag Use of an adeno-associated virus vector to increase the immunogenicity of cells
US7001765B2 (en) 1996-03-06 2006-02-21 Medigene Ag Adeno-associated virus vector for boosting immunogenicity of cells
US5952221A (en) * 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
EP0928202A4 (en) * 1996-09-25 2001-09-05 Cell Genesys Inc Non-invasive administration of adeno-associated viral vectors
EP0943004A2 (en) * 1996-11-18 1999-09-22 McGill University Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
EP2171071B1 (en) 2007-06-15 2015-08-05 Genelux Corporation Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors
EP3921334A1 (en) * 2019-02-08 2021-12-15 Krystal Biotech, Inc. Compositions and methods for delivering cftr polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5252479A (en) * 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy

Also Published As

Publication number Publication date
WO1995027494A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
AU4180596A (en) Functionalised polyorganosiloxanes and one of the processes for the preparation thereof
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
AU4172597A (en) Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
AU3552195A (en) Improved patient-transport and treatment apparatus
AP9700939A0 (en) Compounds and methods for the treatment of cancer
HUP9900330A3 (en) Pyrrolopyrimidines and processes for the preparation thereof
AU2761895A (en) Microwave tomographic spectroscopy system and method
AU3694993A (en) Crosslinked modified polysaccharides having improved absorbent properties and porcess for the preparation thereof
AUPM731194A0 (en) External fixator for military use
EG21559A (en) Novel n-benzylindole and benzopyrazole derivatives with anti-asthmatic-ante-allergic anti-inflammatory and immunemodulating effect
AU2701195A (en) Methods for treating cancer and other cell proliferative diseases
GB9709360D0 (en) Methods for the treatment of herpes virus infections
GB2286927B (en) Antenna and radiotelephone using the same
AU2821295A (en) Compositions and methods for the treatment of tumors
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
AU2283895A (en) Defective herpes and defective adeno-associated virus vectors with p53 for the treatment of cancer
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
AU3634595A (en) Bis-oxazolidines and their use
AU1961695A (en) Triazole compounds and processes for the preparation thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU2577495A (en) Cephalosporin compounds and processes for the preparation thereof
AUPN024994A0 (en) Assay and peptides for use therein
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU1499195A (en) Device for the treatment fo nucleic acids in preparations
AP9500732A0 (en) Anti viral and anti cancer agents